All News

BU Biolab Gets Approval for Research on Deadliest Pathogens

December 27th, 2016 in Featured, In The News, Lab Updates.

Original article from: Boston Globe posted on December 24, 2016. by Evan Allen & Felicia Gans The Centers for Disease Control and Prevention has approved a Biosafety Level 4 laboratory to operate on Boston University’s medical campus in the South End, according to the Boston Public Health Commission. Scientists in the National... More

Zika virus in Nicaragua with Eva Harris, PhD, at EIDA2Z 2016

November 9th, 2016 in EIDA2Z Videos, Video.

Video Courtesy of American Society for Microbiology Eva Harris, PhD, University of California, Berkley, is interviewed by Vincent Racaniello, PhD, Columbia University, New York, about the status of Zika virus in Nicaragua. Harris has developed a multidisciplinary approach to study the molecular virology, pathogenesis, immunology, epidemiology, clinical aspects, and control... More

Emergency Response Exercise to be Conducted November 10, 2016

November 8th, 2016 in Events, Featured, Lab Updates, Press Releases.

FOR IMMEDIATE RELEASE: NOVEMBER 10, 2016 Contact: Colin Riley (617) 353-5386, criley@bu.edu  (Boston) – On Thursday, November 10, between 9 a.m.- noon Boston University (BU) will conduct an emergency response exercise at the National Emerging Infectious Diseases Laboratories (NEIDL) located at 620 Albany Street. This simulation is part of the NEIDL’s ongoing... More

The 9 Deadliest Viruses on Earth

November 4th, 2016 in Featured, In The News.

Original article from: Live Science posted on October 27, 2016. by Anne Harding Humans have been battling viruses since before our species had even evolved into its modern form. For some viral diseases, vaccines and antiviral drugs have allowed us to keep infections from spreading widely, and have helped sick people... More

This Week in Virology: Partnerships Not Parachutes

October 29th, 2016 in Video.

Hosts: Vincent Racaniello, Alan Dove, and Paul Duprex Guests: Ralph Baric, Felix Drexler, Marion Koopmans, and Stacey Schultz-Cherry From the EIDA2Z conference at Boston University, Vincent, Alan and Paul meet up with Ralph Baric, Felix Drexler, Marion Koopmans, Stacey Schultz-Cherry to talk about discovering, understanding, protecting, and collaborating on emerging infectious diseases. Become... More

How would we deal with a global outbreak? – Sir Roy Anderson

October 27th, 2016 in EIDA2Z Videos, Video.

Sir Roy Anderson is a Professor at Imperial College London and the Director of the Centre for Neglected Tropical Disease Research. He told us about the need for an institute combining governments, scientists and industry for rapid action in the case of a global pandemic.

Tuberculosis: A leading cause of death – Prof William Bishai

October 19th, 2016 in EIDA2Z Videos, Video.

Professor William Bishai is co-Director of the Johns Hopkins Center for Tuberculosis Research. He spoke to us at EIDA2Z about the importance of global action on tuberculosis – which, despite being the leading infectious cause of death in the world, rarely makes the headlines.

Disease Surveillance in Uganda – Dr Julius Lutwama

October 11th, 2016 in EIDA2Z Videos, Video.

Dr Julius Lutwama is a virologist at the Uganda Virus Research Institute. We spoke to him at EIDA2Z about studying viruses and diagnosing disease in the countries where they emerge.

A New Lead on Treatment for Ebola

October 11th, 2016 in Featured, In The News, Lab Updates.

Original article from: BU Research posted on September 30, 2016. by Elizabeth Dougherty In the book The Hot Zone, author Richard Preston called viruses like Ebola “molecular sharks”—mindless attackers made of almost nothing. Ebola virus, which causes often-fatal hemorrhagic fevers, carries just seven genes, none of which can do much without... More

Developing local capacity to study emerging viruses – Prof Ian Goodfellow

September 29th, 2016 in EIDA2Z Videos, Video.

Ian Goodfellow is a Professor of Virology at the University of Cambridge. We spoke to him at EIDA2Z about the importance of building local capacity in low- and middle-income countries, so that emerging viruses can be identified and studied at their source.